APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Short Bowel Syndrome (SBS) Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Short Bowel Syndrome (SBS) Drugs Market Analysis and Forecast 2026-2032

Report ID 174035270220 December 2025190 pages

Choose your research edition.

Industry ResearchShort Bowel Syndrome (SBS) Drugs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Short Bowel Syndrome (SBS) Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Short Bowel Syndrome (SBS) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Short Bowel Syndrome (SBS) Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Short Bowel Syndrome (SBS) Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Short Bowel Syndrome (SBS) Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Short Bowel Syndrome (SBS) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Short Bowel Syndrome (SBS) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Short Bowel Syndrome (SBS) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Short Bowel Syndrome (SBS) Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Short Bowel Syndrome (SBS) Drugs include Takeda, Merck, Zealand Pharma, Sancilio Pharmaceuticals, OxThera, Nutrinia, Naia Pharmaceuticals, Emmaus Medical and Ardelyx, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Short Bowel Syndrome (SBS) Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Short Bowel Syndrome (SBS) Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Short Bowel Syndrome (SBS) Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Short Bowel Syndrome (SBS) Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Short Bowel Syndrome (SBS) Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Short Bowel Syndrome (SBS) Drugs sales, projected growth trends, production technology, application and end-user industry.

Short Bowel Syndrome (SBS) Drugs Segment by Company

Takeda

Merck

Zealand Pharma

Sancilio Pharmaceuticals

OxThera

Nutrinia

Naia Pharmaceuticals

Emmaus Medical

Ardelyx

Short Bowel Syndrome (SBS) Drugs Segment by Type

Glutamine

Growth Hormone

Glucagon-Like Peptide-2 (GLP-2)

Other

Short Bowel Syndrome (SBS) Drugs Segment by Application

Hospitals

Clinics

Retail Pharmacies

Short Bowel Syndrome (SBS) Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short Bowel Syndrome (SBS) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Short Bowel Syndrome (SBS) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short Bowel Syndrome (SBS) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Short Bowel Syndrome (SBS) Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Short Bowel Syndrome (SBS) Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Short Bowel Syndrome (SBS) Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Glutamine Major Manufacturers Table 3. Growth Hormone Major Manufacturers Table 4. Glucagon-Like Peptide-2 (GLP-2) Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Manufacturers Table 8. Clinics Major Manufacturers Table 9. Retail Pharmacies Major Manufacturers Table 10. Short Bowel Syndrome (SBS) Drugs Industry Trends Table 11. Short Bowel Syndrome (SBS) Drugs Industry Drivers Table 12. Short Bowel Syndrome (SBS) Drugs Industry Opportunities and Challenges Table 13. Short Bowel Syndrome (SBS) Drugs Industry Restraints Table 14. Global Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Short Bowel Syndrome (SBS) Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Short Bowel Syndrome (SBS) Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Short Bowel Syndrome (SBS) Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2021-2026) & (K Units) Table 21. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2027-2032) & (K Units) Table 22. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2021-2026) Table 23. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2027-2032) Table 24. Global Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Short Bowel Syndrome (SBS) Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Short Bowel Syndrome (SBS) Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Short Bowel Syndrome (SBS) Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Short Bowel Syndrome (SBS) Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Short Bowel Syndrome (SBS) Drugs Manufacturers, Product Type & Application Table 32. Global Short Bowel Syndrome (SBS) Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Short Bowel Syndrome (SBS) Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Short Bowel Syndrome (SBS) Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Short Bowel Syndrome (SBS) Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 42. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2027-2032) & (K Units) Table 43. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2021-2026) Table 44. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2027-2032) Table 45. Global Short Bowel Syndrome (SBS) Drugs Price by Type (2021-2026) & (US$/Unit) Table 46. Global Short Bowel Syndrome (SBS) Drugs Price by Type (2027-2032) & (US$/Unit) Table 47. Global Short Bowel Syndrome (SBS) Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Short Bowel Syndrome (SBS) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Short Bowel Syndrome (SBS) Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2027-2032) & (K Units) Table 55. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2021-2026) Table 56. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2027-2032) Table 57. Global Short Bowel Syndrome (SBS) Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Short Bowel Syndrome (SBS) Drugs Price by Application (2027-2032) & (US$/Unit) Table 59. Takeda Company Information Table 60. Takeda Business Overview Table 61. Takeda Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Takeda Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 63. Takeda Recent Development Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Merck Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 68. Merck Recent Development Table 69. Zealand Pharma Company Information Table 70. Zealand Pharma Business Overview Table 71. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 73. Zealand Pharma Recent Development Table 74. Sancilio Pharmaceuticals Company Information Table 75. Sancilio Pharmaceuticals Business Overview Table 76. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 78. Sancilio Pharmaceuticals Recent Development Table 79. OxThera Company Information Table 80. OxThera Business Overview Table 81. OxThera Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. OxThera Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 83. OxThera Recent Development Table 84. Nutrinia Company Information Table 85. Nutrinia Business Overview Table 86. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Nutrinia Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 88. Nutrinia Recent Development Table 89. Naia Pharmaceuticals Company Information Table 90. Naia Pharmaceuticals Business Overview Table 91. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 93. Naia Pharmaceuticals Recent Development Table 94. Emmaus Medical Company Information Table 95. Emmaus Medical Business Overview Table 96. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 98. Emmaus Medical Recent Development Table 99. Ardelyx Company Information Table 100. Ardelyx Business Overview Table 101. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Ardelyx Short Bowel Syndrome (SBS) Drugs Product Portfolio Table 103. Ardelyx Recent Development Table 104. North America Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Short Bowel Syndrome (SBS) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 107. North America Short Bowel Syndrome (SBS) Drugs Sales by Type (2027-2032) & (K Units) Table 108. North America Short Bowel Syndrome (SBS) Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 109. North America Short Bowel Syndrome (SBS) Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 110. North America Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Short Bowel Syndrome (SBS) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 113. North America Short Bowel Syndrome (SBS) Drugs Sales by Application (2027-2032) & (K Units) Table 114. North America Short Bowel Syndrome (SBS) Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 115. North America Short Bowel Syndrome (SBS) Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 116. North America Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. North America Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 120. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026) & (K Units) Table 121. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2027-2032) & (K Units) Table 122. North America Short Bowel Syndrome (SBS) Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 123. North America Short Bowel Syndrome (SBS) Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 124. United States Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 125. Canada Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 126. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 129. Europe Short Bowel Syndrome (SBS) Drugs Sales by Type (2027-2032) & (K Units) Table 130. Europe Short Bowel Syndrome (SBS) Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 131. Europe Short Bowel Syndrome (SBS) Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 132. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 135. Europe Short Bowel Syndrome (SBS) Drugs Sales by Application (2027-2032) & (K Units) Table 136. Europe Short Bowel Syndrome (SBS) Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 137. Europe Short Bowel Syndrome (SBS) Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Europe Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 142. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026) & (K Units) Table 143. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2027-2032) & (K Units) Table 144. Europe Short Bowel Syndrome (SBS) Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 145. Europe Short Bowel Syndrome (SBS) Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 146. Germany Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 147. France Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 148. U.K. Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 149. Italy Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 151. Nordic Countries Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 152. China Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 153. China Short Bowel Syndrome (SBS) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 154. China Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 155. China Short Bowel Syndrome (SBS) Drugs Sales by Type (2027-2032) & (K Units) Table 156. China Short Bowel Syndrome (SBS) Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 157. China Short Bowel Syndrome (SBS) Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 158. China Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 159. China Short Bowel Syndrome (SBS) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 160. China Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 161. China Short Bowel Syndrome (SBS) Drugs Sales by Application (2027-2032) & (K Units) Table 162. China Short Bowel Syndrome (SBS) Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 163. China Short Bowel Syndrome (SBS) Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 165. Asia Short Bowel Syndrome (SBS) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 166. Asia Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 167. Asia Short Bowel Syndrome (SBS) Drugs Sales by Type (2027-2032) & (K Units) Table 168. Asia Short Bowel Syndrome (SBS) Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Asia Short Bowel Syndrome (SBS) Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Asia Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia Short Bowel Syndrome (SBS) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 173. Asia Short Bowel Syndrome (SBS) Drugs Sales by Application (2027-2032) & (K Units) Table 174. Asia Short Bowel Syndrome (SBS) Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Asia Short Bowel Syndrome (SBS) Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Asia Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Asia Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Asia Short Bowel Syndrome (SBS) Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. Asia Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026) & (K Units) Table 181. Asia Short Bowel Syndrome (SBS) Drugs Sales by Country (2027-2032) & (K Units) Table 182. Asia Short Bowel Syndrome (SBS) Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Asia Short Bowel Syndrome (SBS) Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Japan Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 185. South Korea Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 186. India Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 187. Australia Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 188. China Taiwan Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 189. Southeast Asia Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 190. SAMEA Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 191. SAMEA Short Bowel Syndrome (SBS) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 192. SAMEA Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2026) & (K Units) Table 193. SAMEA Short Bowel Syndrome (SBS) Drugs Sales by Type (2027-2032) & (K Units) Table 194. SAMEA Short Bowel Syndrome (SBS) Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 195. SAMEA Short Bowel Syndrome (SBS) Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 196. SAMEA Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Short Bowel Syndrome (SBS) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2026) & (K Units) Table 199. SAMEA Short Bowel Syndrome (SBS) Drugs Sales by Application (2027-2032) & (K Units) Table 200. SAMEA Short Bowel Syndrome (SBS) Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 201. SAMEA Short Bowel Syndrome (SBS) Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 202. SAMEA Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. SAMEA Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. SAMEA Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. SAMEA Short Bowel Syndrome (SBS) Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 206. SAMEA Short Bowel Syndrome (SBS) Drugs Sales by Country (2021-2026) & (K Units) Table 207. SAMEA Short Bowel Syndrome (SBS) Drugs Sales by Country (2027-2032) & (K Units) Table 208. SAMEA Short Bowel Syndrome (SBS) Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 209. SAMEA Short Bowel Syndrome (SBS) Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 210. Brazil Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 211. Argentina Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 212. Chile Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 213. Colombia Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 214. Peru Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 215. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 216. Israel Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 217. UAE Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 218. Turkey Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 219. Iran Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 220. Egypt Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Short Bowel Syndrome (SBS) Drugs Distributors List Table 224. Short Bowel Syndrome (SBS) Drugs Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Short Bowel Syndrome (SBS) Drugs Image Figure 2. Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Short Bowel Syndrome (SBS) Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Glutamine Image Figure 5. Growth Hormone Image Figure 6. Glucagon-Like Peptide-2 (GLP-2) Image Figure 7. Other Image Figure 8. Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Short Bowel Syndrome (SBS) Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Clinics Image Figure 12. Retail Pharmacies Image Figure 13. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Short Bowel Syndrome (SBS) Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Short Bowel Syndrome (SBS) Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Short Bowel Syndrome (SBS) Drugs Sales (2021-2032) & (K Units) Figure 19. Global Short Bowel Syndrome (SBS) Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Short Bowel Syndrome (SBS) Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Europe Short Bowel Syndrome (SBS) Drugs Sales YoY (2021-2032) & (K Units) Figure 23. China Short Bowel Syndrome (SBS) Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Short Bowel Syndrome (SBS) Drugs Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales YoY (2021-2032) & (K Units) Figure 26. Global Short Bowel Syndrome (SBS) Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Short Bowel Syndrome (SBS) Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Short Bowel Syndrome (SBS) Drugs Revenue Share by Type (2021-2032) Figure 42. North America Short Bowel Syndrome (SBS) Drugs Sales Share by Type (2021-2032) Figure 43. North America Short Bowel Syndrome (SBS) Drugs Revenue Share by Application (2021-2032) Figure 44. North America Short Bowel Syndrome (SBS) Drugs Sales Share by Application (2021-2032) Figure 45. North America Short Bowel Syndrome (SBS) Drugs Revenue Share by Country (2021-2032) Figure 46. North America Short Bowel Syndrome (SBS) Drugs Sales Share by Country (2021-2032) Figure 47. Europe Short Bowel Syndrome (SBS) Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Short Bowel Syndrome (SBS) Drugs Sales Share by Type (2021-2032) Figure 49. Europe Short Bowel Syndrome (SBS) Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Short Bowel Syndrome (SBS) Drugs Sales Share by Application (2021-2032) Figure 51. Europe Short Bowel Syndrome (SBS) Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Short Bowel Syndrome (SBS) Drugs Sales Share by Country (2021-2032) Figure 53. China Short Bowel Syndrome (SBS) Drugs Revenue Share by Type (2021-2032) Figure 54. China Short Bowel Syndrome (SBS) Drugs Sales Share by Type (2021-2032) Figure 55. China Short Bowel Syndrome (SBS) Drugs Revenue Share by Application (2021-2032) Figure 56. China Short Bowel Syndrome (SBS) Drugs Sales Share by Application (2021-2032) Figure 57. Asia Short Bowel Syndrome (SBS) Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Short Bowel Syndrome (SBS) Drugs Sales Share by Type (2021-2032) Figure 59. Asia Short Bowel Syndrome (SBS) Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Short Bowel Syndrome (SBS) Drugs Sales Share by Application (2021-2032) Figure 61. Asia Short Bowel Syndrome (SBS) Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Short Bowel Syndrome (SBS) Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Short Bowel Syndrome (SBS) Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Short Bowel Syndrome (SBS) Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Short Bowel Syndrome (SBS) Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Short Bowel Syndrome (SBS) Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Short Bowel Syndrome (SBS) Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Short Bowel Syndrome (SBS) Drugs Sales Share by Country (2021-2032) Figure 69. Short Bowel Syndrome (SBS) Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Short Bowel Syndrome (SBS) Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Glutamine
  • Growth Hormone
  • Glucagon-Like Peptide-2 (GLP-2)
  • Other
Applications
  • Hospitals
  • Clinics
  • Retail Pharmacies
Companies covered
  • Takeda
  • Merck
  • Zealand Pharma
  • Sancilio Pharmaceuticals
  • OxThera
  • Nutrinia
  • Naia Pharmaceuticals
  • Emmaus Medical
  • Ardelyx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Short Bowel Syndrome (SBS) Drugs Market by Type
  3. 1.2.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Glutamine
  5. 1.2.3 Growth Hormone
  6. 1.2.4 Glucagon-Like Peptide-2 (GLP-2)
  7. 1.2.5 Other
  8. 1.3 Short Bowel Syndrome (SBS) Drugs Market by Application
  9. 1.3.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Clinics
  12. 1.3.4 Retail Pharmacies
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Short Bowel Syndrome (SBS) Drugs Market Dynamics
  1. 2.1 Short Bowel Syndrome (SBS) Drugs Industry Trends
  2. 2.2 Short Bowel Syndrome (SBS) Drugs Industry Drivers
  3. 2.3 Short Bowel Syndrome (SBS) Drugs Industry Opportunities and Challenges
  4. 2.4 Short Bowel Syndrome (SBS) Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Short Bowel Syndrome (SBS) Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region
  3. 3.2.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Short Bowel Syndrome (SBS) Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Short Bowel Syndrome (SBS) Drugs Sales by Region
  9. 3.4.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturers
  2. 4.1.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Short Bowel Syndrome (SBS) Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Manufacturers
  6. 4.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Short Bowel Syndrome (SBS) Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Short Bowel Syndrome (SBS) Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Short Bowel Syndrome (SBS) Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Short Bowel Syndrome (SBS) Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Short Bowel Syndrome (SBS) Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Short Bowel Syndrome (SBS) Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Short Bowel Syndrome (SBS) Drugs Market CR5 and HHI
  16. 4.8.2 2025 Short Bowel Syndrome (SBS) Drugs Tier 1, Tier 2, and Tier 3
5 Short Bowel Syndrome (SBS) Drugs Market by Type
  1. 5.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type
  2. 5.1.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Type
  6. 5.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Short Bowel Syndrome (SBS) Drugs Price by Type
6 Short Bowel Syndrome (SBS) Drugs Market by Application
  1. 6.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Application
  2. 6.1.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Application
  6. 6.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Short Bowel Syndrome (SBS) Drugs Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Short Bowel Syndrome (SBS) Drugs Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Short Bowel Syndrome (SBS) Drugs Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Zealand Pharma
  14. 7.3.1 Zealand Pharma Company Information
  15. 7.3.2 Zealand Pharma Business Overview
  16. 7.3.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Portfolio
  18. 7.3.5 Zealand Pharma Recent Developments
  19. 7.4 Sancilio Pharmaceuticals
  20. 7.4.1 Sancilio Pharmaceuticals Company Information
  21. 7.4.2 Sancilio Pharmaceuticals Business Overview
  22. 7.4.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
  24. 7.4.5 Sancilio Pharmaceuticals Recent Developments
  25. 7.5 OxThera
  26. 7.5.1 OxThera Company Information
  27. 7.5.2 OxThera Business Overview
  28. 7.5.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 OxThera Short Bowel Syndrome (SBS) Drugs Product Portfolio
  30. 7.5.5 OxThera Recent Developments
  31. 7.6 Nutrinia
  32. 7.6.1 Nutrinia Company Information
  33. 7.6.2 Nutrinia Business Overview
  34. 7.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Product Portfolio
  36. 7.6.5 Nutrinia Recent Developments
  37. 7.7 Naia Pharmaceuticals
  38. 7.7.1 Naia Pharmaceuticals Company Information
  39. 7.7.2 Naia Pharmaceuticals Business Overview
  40. 7.7.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
  42. 7.7.5 Naia Pharmaceuticals Recent Developments
  43. 7.8 Emmaus Medical
  44. 7.8.1 Emmaus Medical Company Information
  45. 7.8.2 Emmaus Medical Business Overview
  46. 7.8.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Portfolio
  48. 7.8.5 Emmaus Medical Recent Developments
  49. 7.9 Ardelyx
  50. 7.9.1 Ardelyx Company Information
  51. 7.9.2 Ardelyx Business Overview
  52. 7.9.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Product Portfolio
  54. 7.9.5 Ardelyx Recent Developments
8 North America
  1. 8.1 North America Short Bowel Syndrome (SBS) Drugs Market Size by Type
  2. 8.1.1 North America Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Short Bowel Syndrome (SBS) Drugs Price by Type (2021-2032)
  5. 8.2 North America Short Bowel Syndrome (SBS) Drugs Market Size by Application
  6. 8.2.1 North America Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Short Bowel Syndrome (SBS) Drugs Price by Application (2021-2032)
  9. 8.3 North America Short Bowel Syndrome (SBS) Drugs Market Size by Country
  10. 8.3.1 North America Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Short Bowel Syndrome (SBS) Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Type
  2. 9.1.1 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Short Bowel Syndrome (SBS) Drugs Price by Type (2021-2032)
  5. 9.2 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Application
  6. 9.2.1 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Short Bowel Syndrome (SBS) Drugs Price by Application (2021-2032)
  9. 9.3 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Country
  10. 9.3.1 Europe Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Short Bowel Syndrome (SBS) Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Short Bowel Syndrome (SBS) Drugs Market Size by Type
  2. 10.1.1 China Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Short Bowel Syndrome (SBS) Drugs Price by Type (2021-2032)
  5. 10.2 China Short Bowel Syndrome (SBS) Drugs Market Size by Application
  6. 10.2.1 China Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Short Bowel Syndrome (SBS) Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Short Bowel Syndrome (SBS) Drugs Market Size by Type
  2. 11.1.1 Asia Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Short Bowel Syndrome (SBS) Drugs Price by Type (2021-2032)
  5. 11.2 Asia Short Bowel Syndrome (SBS) Drugs Market Size by Application
  6. 11.2.1 Asia Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Short Bowel Syndrome (SBS) Drugs Price by Application (2021-2032)
  9. 11.3 Asia Short Bowel Syndrome (SBS) Drugs Market Size by Country
  10. 11.3.1 Asia Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Short Bowel Syndrome (SBS) Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Short Bowel Syndrome (SBS) Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Short Bowel Syndrome (SBS) Drugs Market Size by Type
  2. 12.1.1 SAMEA Short Bowel Syndrome (SBS) Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Short Bowel Syndrome (SBS) Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Short Bowel Syndrome (SBS) Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Short Bowel Syndrome (SBS) Drugs Market Size by Application
  6. 12.2.1 SAMEA Short Bowel Syndrome (SBS) Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Short Bowel Syndrome (SBS) Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Short Bowel Syndrome (SBS) Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Short Bowel Syndrome (SBS) Drugs Market Size by Country
  10. 12.3.1 SAMEA Short Bowel Syndrome (SBS) Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Short Bowel Syndrome (SBS) Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Short Bowel Syndrome (SBS) Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Short Bowel Syndrome (SBS) Drugs Value Chain Analysis
  2. 13.1.1 Short Bowel Syndrome (SBS) Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Short Bowel Syndrome (SBS) Drugs Production Mode & Process
  6. 13.2 Short Bowel Syndrome (SBS) Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Short Bowel Syndrome (SBS) Drugs Distributors
  9. 13.2.3 Short Bowel Syndrome (SBS) Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst